前往化源商城

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺

更新时间:2025-09-08 11:18:56

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式
(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式
品牌特惠专场
常用名 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺 英文名 (S)-5-METHOXY-N-PROPYL-1,2,3,4-TETRAHYDRONAPHTHALEN-2-AMINE
CAS号 101403-24-1 分子量 219.323
密度 1.0±0.1 g/cm3 沸点 346.1±42.0 °C at 760 mmHg
分子式 C14H21NO 熔点 N/A
MSDS N/A 闪点 143.3±17.3 °C

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺名称

中文名 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺
英文名 (2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine
英文别名 更多

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺物理化学性质

密度 1.0±0.1 g/cm3
沸点 346.1±42.0 °C at 760 mmHg
分子式 C14H21NO
分子量 219.323
闪点 143.3±17.3 °C
精确质量 219.162308
PSA 21.26000
LogP 3.17
蒸汽压 0.0±0.8 mmHg at 25°C
折射率 1.533

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺安全信息

海关编码 2922299090

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺合成线路

~96%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:KANDULA, Mahesh Patent: WO2013/168033 A1, 2013 ; Location in patent: Paragraph 0099; 00100 ;

~98%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Marquillas Olondriz, Francisco; Pomares Marco, Marta Patent: US2011/152543 A1, 2011 ; Location in patent: Page/Page column 3 ;

~85%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Seiler, Max P.; Stoll, Andre P.; Closse, Annemarie; Frick, Willy; Jaton, Annelise; Vigouret, Jean-Marie Journal of Medicinal Chemistry, 1986 , vol. 29, # 6 p. 912 - 917

~92%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Homan, Evert J.; Copinga, Swier; Unelius, Lena; Jackson, David M.; Wikstroem, Hkan V.; Grol, Cor J. Bioorganic and Medicinal Chemistry, 1999 , vol. 7, # 7 p. 1263 - 1271

~%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Journal of Medicinal Chemistry, , vol. 29, # 6 p. 912 - 917

~%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Journal of Medicinal Chemistry, , vol. 34, # 11 p. 3235 - 3241

~%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Journal of Medicinal Chemistry, , vol. 38, # 8 p. 1319 - 1329

~%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Journal of Medicinal Chemistry, , vol. 34, # 11 p. 3235 - 3241

~%

(S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺结构式

(S)-5-甲氧基-1,2,3...

101403-24-1

文献:Journal of Medicinal Chemistry, , vol. 34, # 11 p. 3235 - 3241

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺海关

海关编码 2922299090
中文概述 2922299090. 其他氨基(萘酚、酚)及醚、酯〔包括它们的盐, 但含有一种以上含氧基的除外〕. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%
申报要素 品名, 成分含量, 用途, 乙醇胺及其盐应报明色度, 乙醇胺及其盐应报明包装
Summary 2922299090. other amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

 (S)-5-甲氧基-1,2,3,4-四氢-N-丙基-2-萘胺英文别名

(2S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine
(S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine
(-)-(2S)-2-(n-propylamino)-5-methoxytetralin
(S)-(5-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)propylamine
(-)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine
(S)-1,2,3,4-tetrahydro-5-methoxy-N-propyl-2-Naphthalenamine(Rotigotine)
(S)-(-)-2-(N-propylamino)-5-methoxytetraline
(S)-(-)-2-(N-propylamino)-5-methoxytetralin
(2S)-5-Methoxy-N-propyl-1,2,3,4-tetrahydro-2-naphthalenamine
2-Naphthalenamine, 1,2,3,4-tetrahydro-5-methoxy-N-propyl-, (2S)-
(S)-(5-methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-propylamine hydrochloride
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。
相关化合物: 更多...
(S)-5-甲氧基-1,2,3,4-四氢-N-(苯甲基)-2-萘胺
58349-23-8
(S)-1,2,3,4-四氢-5-甲氧基-N-丙基-2-萘胺盐酸盐
93601-86-6
N-苯甲基-5-甲氧基-1,2,3,4-四氢萘-2-胺
136247-07-9
(S)-5-甲氧基-1,2,3,4-四氢萘-1-胺盐酸盐
2829279-66-3
罗替戈汀中间体一
58349-17-0
(S)-6-甲氧基-1,2,3,4-四氢-2-萘胺
177017-69-5
(S)-5-甲氧基-n-丙基-n-(2-(噻吩-2-基)乙基)-1,2,3,4-四氢萘-2-胺
101945-65-7
(R)-5-甲氧基-1,2,3,4-四氢萘-1-胺盐酸盐
2829279-65-2
2-氨基-8-甲氧基-1,2,3,4-四氢萘盐酸盐
3880-76-0
N-{3-[2-(3,4-dimethoxyphenyl)ethyl]-1H-1,2,4-triazol-5-yl}pyridine-4-carboxamide
1574493-94-9
o-((2-Isopropylthiazol-4-yl)methyl)hydroxylamine
1539112-10-1
(2S)-N-[2-({3-bromo-1-methyl-1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-ylidene}amino)ethyl]-1-(prop-2-yn-1-yl)pyrrolidine-2-carboxamide
2093997-92-1
(2S)-N-{1-[2-(morpholin-4-yl)ethyl]-1H-pyrazol-4-yl}-1-(prop-2-yn-1-yl)pyrrolidine-2-carboxamide
1376275-27-2
(2S)-1-(prop-2-yn-1-yl)-N-(1-{[(pyridin-3-yl)carbamoyl]methyl}-1H-pyrazol-4-yl)pyrrolidine-2-carboxamide
1376347-06-6
3-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-1-[(2S)-1-(prop-2-yn-1-yl)pyrrolidine-2-carbonyl]piperidine
1375830-11-7
(2S)-N-[1-({imidazo[1,2-a]pyridin-2-yl}methyl)-1H-pyrazol-4-yl]-1-(prop-2-yn-1-yl)pyrrolidine-2-carboxamide
1376262-61-1
(2S)-1-(prop-2-yn-1-yl)-N-{[5-(thiophen-3-yl)-1,2,4-oxadiazol-3-yl]methyl}pyrrolidine-2-carboxamide
1384715-01-8
(2S)-N-{1-[(oxolan-2-yl)methyl]-1H-pyrazol-4-yl}-1-(prop-2-yn-1-yl)pyrrolidine-2-carboxamide
1375830-28-6
5-((Piperidin-4-yloxy)methyl)thiazole
1420940-06-2